Singular Genomics Systems Stock Price Prediction

Intrinsic Valuation Low Real High 0.54 10.82 28.47 Details

Earnings Estimates (0) Low Projected EPS High -8.61 -8.61 -8.61 Details

Singular Genomics After-Hype Price Prediction Density Analysis

Singular Genomics Estimiated After-Hype Price Volatility

Singular Genomics Stock Price Prediction Analysis

Expected Return	Period Volatility	Hype Elasticity	Related Elasticity	News Density	Related Density	Expected Hype
2.92	17.52	1.43	0.60	7 Events / Month	7 Events / Month	In about 7 days

Latest traded price	Expected after-news price	Potential return on next major news	Average after-hype volatility
21.90	20.36	6.65	3,576   Notes

Singular Genomics Hype Timeline

Singular Genomics Systems is now traded for 21.90. The entity has historical hype elasticity of -1.43, and average elasticity to hype of competition of -0.6. Singular is forecasted to decline in value after the next headline, with the price expected to drop to 20.36. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -6.65%, whereas the daily expected return is now at 2.92%. The volatility of related hype on Singular Genomics is about 8546.34%, with the expected price after the next announcement by competition of 21.30. About 14.0% of the company outstanding shares are owned by corporate insiders. The company has price-to-book ratio of 0.44. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Singular Genomics Systems recorded a loss per share of 34.68. The entity had not issued any dividends in recent years. The firm had 1:30 split on the 26th of June 2024. Given the investment horizon of 90 days the next forecasted press release will be in about 7 days. Check out Singular Genomics Basic Forecasting Models to cross-verify your projections.

Singular Genomics Related Hype Analysis

Singular Genomics Additional Predictive Modules

Most predictive techniques to examine Singular price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Singular using various technical indicators. When you analyze Singular charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

The successful prediction of Singular Genomics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Singular Genomics Systems, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Singular Genomics based on analysis of Singular Genomics hews, social hype, general headline patterns, and widely used predictive technical indicators.

The number of cover stories for Singular Genomics depends on current market conditions and Singular Genomics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Singular Genomics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Singular Genomics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Singular Genomics' future price predictability will typically decrease when Singular Genomics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Singular Genomics Systems often depends not only on the future outlook of the potential Singular Genomics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Singular Genomics' indicators that are reflective of the short sentiment are summarized in the table below.

When running Singular Genomics' price analysis, check to measure Singular Genomics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Singular Genomics is operating at the current time. Most of Singular Genomics' value examination focuses on studying past and present price action to predict the probability of Singular Genomics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Singular Genomics' price. Additionally, you may evaluate how the addition of Singular Genomics to your portfolios can decrease your overall portfolio volatility.